Clinical trials
Phase 1/2 Hematologic Neoplasms trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2011 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 3 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| University Hospital Tuebingen | 2 |
| AGC Biologics S.p.A. | 1 |
| Clavis Pharma | 1 |
| European Myeloma Network B.V. | 1 |
| Glycostem Therapeutics BV | 1 |
| ImCheck Therapeutics, an Ipsen company | 1 |
| Kura Oncology, Inc. | 1 |
| medac GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 11 |
| Leukemia | 3 |
| Neoplasms | 3 |
| Leukemia, Myeloid, Acute | 2 |
| Leukemia, Biphenotypic, Acute | 1 |
| Multiple Myeloma | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.